Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Coherus Oncology
CHRS
$222M
| $10.3M | 0.01% |
643,200
-211,109
| -25% | -$3.09M |
|
|
COR
1377
DELISTED
Coresite Realty Corporation
COR
| $10.3M | 0.01% |
74,576
-12,799
| -15% | -$1.83M |
|
1378
PUT
Deutsche Bank
DB
$67.6B
| $10.3M | 0.01% |
810,000
+160,000
| +25% | +$2.01M |
|
1379
CALL
AbCellera Biologics
ABCL
$1.62B
| $10.3M | 0.01% |
513,700
+196,100
| +62% | +$3.47M |
|
1380
PUT
American International
AIG
$42.9B
| $10.3M | 0.01% |
187,500
+22,500
| +14% | +$1.16M |
|
1381
Invesco PHLX Semiconductor ETF
SOXQ
$2.22B
| $10.3M | 0.01% |
400,000
| – | – |
|
1382
PUT
New Oriental
EDU
$8.08B
| $10.3M | 0.01% |
+500,000
| New | +$15.9M |
|
|
CNH
1383
CNH Industrial
CNH
$14.2B
| $10.2M | 0.01% |
708,731
-215,528
| -23% | -$3.09M |
|
1384
Invesco NASDAQ Biotechnology ETF
IBBQ
$76.7M
| $10.2M | 0.01% |
400,000
| – | – |
|
|
Y
1385
DELISTED
Alleghany Corp
Y
| $10.2M | 0.01% |
16,387
+1,998
| +14% | +$1.32M |
|
1386
Workiva
WK
$3.28B
| $10.2M | 0.01% |
72,370
-7,304
| -9% | -$990K |
|
1387
CALL
Boston Beer
SAM
$1.93B
| $10.2M | 0.01% |
+20,000
| New | +$13.6M |
|
1388
iShares 20+ Year Treasury Bond ETF
TLT
$43.1B
| $10.2M | 0.01% |
70,612
-734,043
| -91% | -$109M |
|
1389
DT Midstream
DTM
$14.1B
| $10.2M | 0.01% |
219,970
+172,927
| +368% | +$7.57M |
|
1390
Kilroy Realty
KRC
$4.5B
| $10.1M | 0.01% |
153,192
-56,197
| -27% | -$3.79M |
|
|
FINV
1391
FinVolution Group
FINV
$1.16B
| $10.1M | 0.01% |
1,798,060
-580,480
| -24% | -$3.82M |
|
1392
CALL
Honeywell
HON
$78.3B
| $10.1M | 0.01% |
50,504
+10,823
| +27% | +$2.31M |
|
1393
Invesco
IVZ
$13B
| $10.1M | 0.01% |
417,520
-65,757
| -14% | -$1.64M |
|
1394
Fate Therapeutics
FATE
$270M
| $10M | 0.01% |
169,522
+107,772
| +175% | +$8.45M |
|
|
CTLT
1395
DELISTED
CATALENT, INC.
CTLT
| $10M | 0.01% |
75,422
-275,970
| -79% | -$34.5M |
|
1396
PUT
NextEra Energy
NEE
$186B
| $10M | 0.01% |
127,800
-31,400
| -20% | -$2.53M |
|
1397
Macy's
M
$6.62B
| $10M | 0.01% |
443,355
-107,095
| -19% | -$2.14M |
|
1398
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $10M | 0.01% |
257,602
-169,587
| -40% | -$6.65M |
|
1399
Lincoln National
LNC
$8.19B
| $10M | 0.01% |
145,401
-32,669
| -18% | -$2.13M |
|
1400
Dentsply Sirona
XRAY
$2.7B
| $9.98M | 0.01% |
171,947
-79,309
| -32% | -$4.89M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.